William Blair initiates coverage of digital finance stocks
Fintech Leaders: SoFi and Affirm Shine as William Blair Kicks Off Coverage with Outperform Ratings
With Outperform ratings on both stocks, SoFi Technologies ( NASDAQ:SOFI) and Affirm Holdings ( NASDAQ:AFRM) shares moved higher on Wednesday after William Blair started coverage of the digital finance industry.
Enfusion (ENFN – Research Report) received a Hold rating and price target from William Blair analyst Dylan Becker today. The company’s shares ...
Equities research analysts at William Blair cut their FY2024 earnings per share estimates for shares of MarketAxess in a ...
William Blair has upgraded CVRx (NASDAQ:CVRX) to outperform from market perform, citing utilization improvements and ...
On Friday, Federal Signal Corp (FSS) stock saw a decline, ending the day at $97.2 which represents a decrease of $-0.64 or -0.65% from the prior close of $97.84. The stock opened at $99.37 and touched ...
William Blair boosted their FY2024 earnings per share estimates for Certara in a research note issued on Wednesday, January 15th. William Blair analyst M. Smock now expects that the company will earn ...
William Blair Small-Mid Cap Growth Fund earns a Below Average Process Pillar rating. The process benefits from its parent firm's long-term risk-adjusted performance, as shown by the firm's average ...
On Friday, Generation Bio Co (GBIO) stock saw a modest uptick, ending the day at $0.95 which represents no change from the prior close of of $0.95. The stock opened at $0.96 and touched a low of $0.94 ...
CHICAGO, January 07, 2025--(BUSINESS WIRE)--William Blair, the premier global boutique with expertise in investment banking, investment management, and private wealth management, has named Stewart ...
The Fund seeks long-term capital appreciation. Under normal market conditions, the Fund invests at least 80% of its total assets in a diversified portfolio of equity securities, including common ...
William Blair reaffirmed their outperform rating on shares of Denali Therapeutics (NASDAQ:DNLI – Free Report) in a report ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback